Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 57 out of 100. How common it is

Topic: Risk, prevention and care in population studies

Plain-language summary

Data from 1,272,495 individuals, with the mean age at diagnosis ranging from 76.8 years (South Korea) to 82.9 years (Germany), show that the overall median length of survival following recorded diagnosis ranges from 2.4 years (New Zealand) to 7.9 years (South Korea). In five of these regions, people diagnosed with dementia in more recent years had a lower risk of dying compared to those diagnosed in earlier years.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 1,272,495 participants. This multinational cohort study found that median survival after dementia diagnosis ranged from 2.4 to 7.9 years across regions, and in five regions people diagnosed more recently had a lower risk of dying. It describes survival trends and does not test any treatment, cure, or prevention.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Luo, H., Koponen, M., Roethlein, C., Becker, C., Bell, J. S., Beyene, K. A., et al. (2025). A multinational cohort study of trends in survival following dementia diagnosis. Communications Medicine. https://doi.org/10.1038/s43856-025-00923-6

Vancouver

Luo H, Koponen M, Roethlein C, Becker C, Bell JS, Beyene KA, et al. A multinational cohort study of trends in survival following dementia diagnosis. Communications Medicine. 2025. doi:10.1038/s43856-025-00923-6. PMID: 40437158.

BibTeX

@article{luo2025-40437158,
  author  = {Luo, Hao and Koponen, Marjaana and Roethlein, Christoph and Becker, Cornelia and Bell, J. Simon and Beyene, Kebede Abera and Chai, Yi and Chan, Amy Hai Yan and others},
  title   = {{A multinational cohort study of trends in survival following dementia diagnosis}},
  journal = {Communications Medicine},
  year    = {2025},
  doi     = {10.1038/s43856-025-00923-6},
  pmid    = {40437158},
  url     = {https://doi.org/10.1038/s43856-025-00923-6}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This multinational cohort study found that median survival after dementia diagnosis ranged from 2.4 to 7.9 years across regions, and in five regions people diagnosed more recently had a lower risk of dying. It describes survival trends and does not test any treatment, cure, or prevention.

Study details

How this study scored 57/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 57 of 100.57 of 100 points earned43 not earned

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Communications Medicine)
Journal's citation record 0 / 4 Communications Medicine: journal h-index 55 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 1,272,495 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 8 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.7 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 5.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Ian Chi Kei Wong: h-index 85 (OpenAlex, whole career)
Institution's track record 2 / 3 University College London: institution h-index 2,029 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 20 institution(s) in 10 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40437158)
Free to read 2 / 2 Free to read
Total 57 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in How common it is from nearby years

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on How common it is

See all studies in How common it is →